NCT03636048

Brief Summary

The investigator aimed to compare the effect of anesthesia on overall postoperative outcomes including post-operative pain score and the fetal well-being (heart rate) in patients undergoing transabdominal cervico isthmic cerclage(TCIC). The investigator divided the patients into two groups. The first group was the patients who undergo general anesthesia with postoperative wound patient-controlled analgesia device(PCA) and the second group was the patients who undergo combined spinal-epidural anesthesia(CSE) with postoperative epidural catheter PCA device for pain control.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 1, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

August 1, 2018

Completed
16 days until next milestone

First Posted

Study publicly available on registry

August 17, 2018

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

September 4, 2020

Status Verified

January 1, 2020

Enrollment Period

1.8 years

First QC Date

August 1, 2018

Last Update Submit

September 2, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Pain score at 24hours after the end of the operation

    Numerical Rating Score(0-10), 0:no pain, 5:moderate pain, 10:worst pain

    Assessed by directly asking to the patient, from date of randomization up to postoperative day 3.

Secondary Outcomes (1)

  • Fetal viability on postoperative day 5

    Assessed by ultrasonography, upto postoperative day 5.

Study Arms (2)

Spinal anesthesia group

EXPERIMENTAL

Spinal anesthesia is used for operation with epidural patient-controlled device for pain control. Bupivacaine Hcl 0.5% Inj. 9-10mg is injected into intrathecal space for anesthesia. 0.2% ropivacaine is used for postoperative pain control with continuous infusion into epidural space.

Drug: Bupivacaine Hcl 0.5% Inj

General anesthesia group

ACTIVE COMPARATOR

General anesthesia is used for operation with wound patient-controlled device for pain control. propofol (10milligram/ML) 1.5-2 mg/ml is used as bolus intravascular injection for induction of anesthesia. 0.5% ropivacaine is used for postoperative pain control with continous infusion through wound catheter.

Drug: Propofol 10 milligram/ML

Interventions

The patients undergo surgery under spinal anesthesia and a catheter would be inserted into epidural space during the procedure. 0.5% bupivacaine is injected into intrathecal space for spinal anesthesia. For pain control, 0.2% ropivacaine is continuously infused into epidural space postoperatively.

Also known as: Spinal anesthesia with epidural patient-controlled analgesia
Spinal anesthesia group

The patients undergo surgery under general anesthesia and a catheter would be inserted to abdominal incision site at the end of the operation. Propofol is used for induction of general anesthesia, and sevoflurane is used for maintenance of anesthesia. At the end of the operation, the surgeon inserts wound catheter in the surgical site and connects wound patient-controlled analgesia device filled with 0.5% ropivacaine.

Also known as: general anesthesia with wound patient-controlled analgesia
General anesthesia group

Eligibility Criteria

Age20 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Patients who undergo TCIC for IIOC and agree to participate in this study.

You may not qualify if:

  • Hepatic failure
  • Chronic kidney disease(\>stage III)
  • Hypersensitivity, allergic response and/or resistance to drugs used in this study(ex. pethidine, ropivacaine)
  • Spinal anesthesia is not possible
  • Refuse to participate in the study
  • Cannot understand the agreement
  • Body weight is under 50 kg or over 100 kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kangnam sungshim hospital

Seoul, South Korea

Location

MeSH Terms

Conditions

Uterine Cervical Incompetence

Interventions

BupivacaineAnesthesia, SpinalAnesthesia, General

Condition Hierarchy (Ancestors)

Uterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesAbortion, HabitualAbortion, SpontaneousPregnancy ComplicationsGenital Diseases

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesAnesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Eunmi Choi, MD.PhD

    Kangnam sungshim hospital

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2018

First Posted

August 17, 2018

Study Start

August 1, 2018

Primary Completion

June 1, 2020

Study Completion

June 1, 2020

Last Updated

September 4, 2020

Record last verified: 2020-01

Locations